PAGS Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Mixed Market Reaction BRBI Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment Innventure Inc Q1 2026 Earnings NarrowerThanExpected Loss Drives Mixed Market Reaction Lesaka Technologies Q1 2026 Earnings EPS Surges Past Estimates with 978 Surprise Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending